Unternehmensprofil · Healthcare

SCHOTT Pharma AG & Co. KGaA

1SXP · XETRA
Branche
Packaging
Börse
XETRA
Land / Region
Germany
Mitarbeiter
4.839
Aktueller Kurs
€24.7
Live · 5. Oktober 2026
Fairer Kauf
≤ €18
Einstieg mit Sicherheitsmarge
Baillie-Wachstumsscore
35/100
Eher schwach
Buffett Score
67/100
Stark
Innerer Wert · Drei-Stufen-Bereich Aktueller Kurs €24.7 Live · Innerhalb des fairen Bereichs des inneren Werts

Zusammengesetzter Bewertungsbereich · konservativ €16–€18 / fair €22–€30 / optimistisch €38–€42. Bei €24.7, Innerhalb des fairen Bereichs des inneren Werts.

Bei Veröffentlichung €22.15 (6. August 2026)

Marktkapitalisierung2,65 Mrd. €
Umsatz (TTM)991,22 Mio. €
EBITDA256,22 Mio. €
Nettomarge14,41 %
ROE16,08 %
KGV (TTM)18,55
Erwartetes KGV20,2
EPS0,95 €
Dividendenrendite1,04 %
52-Wochen-Spanne12,62 € – 29,87 €

Daten von EODHD, dargestellt in der Berichtswährung; nur zu Informationszwecken, keine Anlageberatung.

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.

Geschichte

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Branchenposition

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.